If you've noticed an error on the site, the information is inaccurate, or something is missing — let us know! Or maybe you'd like to suggest an idea — we'd love to hear it.
Specialists from the National Cancer Institute have begun participating in the international SCALE project (Strengthening Health Workforce Capacity through Global Learning) — an initiative aimed at strengthening the healthcare workforce through global professional exchange.
The project is being implemented in partnership with The Christie Institute for Cancer Education Manchester and The Christie NHS Foundation Trust, and is funded by NHS England through the Global Health Partnerships program (formerly THET) with support from the UK Department of Health and Social Care.
The initiative is part of the broader International Medical Partnership Programme, which aims to build sustainable institutional ties between healthcare institutions in the UK and Ukraine.
The project involves visits by three groups of Ukrainian specialists, who will undergo individually tailored training in the following areas:
Professional mentorship for participants is provided by leading experts from The Christie. Participation in the program includes observing clinical practice, working with multidisciplinary teams, and learning about modern approaches to cancer treatment and care organization.
The National Cancer Institute sincerely thanks its partners at The Christie Institute for Cancer Education Manchester for their warm welcome, openness to cooperation, and consistent support of Ukrainian medical specialists amid the hardships of war.
Initiatives like this play a key role in developing human capital, improving the quality of cancer care, and integrating Ukrainian medicine into the international professional community.
The 2026 class of interns has joined the Institute's team. Ahead of them lie clinical practice, mentorship from experienced specialists, and their first independent decisions.
A third high-precision radiation therapy unit will reduce waiting times and expand access to treatment for more patients.
The drug has been purchased with state budget funds for the first time. Who can join the program, which documents to prepare, and how to schedule a multidisciplinary board review.
